Neuroprotective Effects of Resveratrol in Ischemic Brain Injury

Autores
Machado, Noelia Daiana; Villena Armas, Gorka; Fernández, Mariana Adela; Grijalvo, Santiago; Díaz Díaz, David
Año de publicación
2021
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Cerebral ischemia represents the third cause of death and the first cause of disability inadults. This process results from decreasing cerebral blood flow levels as a result of the occlusionof a major cerebral artery. This restriction in blood supply generates low levels of oxygen andglucose, which leads to a decrease in the energy metabolism of the cell, producing inflammation, andfinally, neurological deterioration. Currently, blood restoration of flow is the only effective approachas a therapy in terms of ischemic stroke. However, a significant number of patients still have apoor prognosis, probably owing to the increase in the generation of reactive oxygen species (ROS)during the reperfusion of damaged tissue. Oxidative stress and inflammation can be avoided bymodulating mitochondrial function and have been identified as potential targets for the treatmentof cerebral ischemia. In recent years, the beneficial actions of flavonoids and polyphenols againstcerebrovascular diseases have been extensively investigated. The use of resveratrol (RSV) has beenshown to markedly decrease brain damage caused by ischemia in numerous studies. According toin vitro and in vivo experiments, there is growing evidence that RSV is involved in several pathways,including cAMP/AMPK/SIRT1 regulation, JAK/ERK/STAT signaling pathway modulation, TLR4signal transduction regulation, gut/brain axis modulation, GLUT3 up-regulation inhibition, neuronalautophagy activation, and de novo SUR1 expression inhibition. In this review, we summarize therecent outcomes based on the neuroprotective effect of RSV itself and RSV-loaded nanoparticlesin vitro and in vivo models focusing on such mechanisms of action as well as describing the potentialtherapeutic strategies in which RSV plays an active role in cases of ischemic brain injury
Fil: Machado, Noelia Daiana. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; Argentina. Universidad Nacional de Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada; Argentina
Fil: Villena Armas, Gorka. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; España
Fil: Fernández, Mariana Adela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigaciones en Físico-química de Córdoba. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Instituto de Investigaciones en Físico-química de Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; Argentina
Fil: Grijalvo, Santiago. Institute For Advanced Chemistry Of Catalonia; España. Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine; España
Fil: Díaz Díaz, David. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; España. Universitat Regensburg; Alemania
Materia
BLOOD BRAIN BARRIER
BRAIN
ISCHEMIA
NEUROPROTECTION
OXIDATIVE STRESS
POLYPHENOLS
RESVERATROL
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/172967

id CONICETDig_d0f7c0b45bf806b594b73061125a59e4
oai_identifier_str oai:ri.conicet.gov.ar:11336/172967
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Neuroprotective Effects of Resveratrol in Ischemic Brain InjuryMachado, Noelia DaianaVillena Armas, GorkaFernández, Mariana AdelaGrijalvo, SantiagoDíaz Díaz, DavidBLOOD BRAIN BARRIERBRAINISCHEMIANEUROPROTECTIONOXIDATIVE STRESSPOLYPHENOLSRESVERATROLhttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Cerebral ischemia represents the third cause of death and the first cause of disability inadults. This process results from decreasing cerebral blood flow levels as a result of the occlusionof a major cerebral artery. This restriction in blood supply generates low levels of oxygen andglucose, which leads to a decrease in the energy metabolism of the cell, producing inflammation, andfinally, neurological deterioration. Currently, blood restoration of flow is the only effective approachas a therapy in terms of ischemic stroke. However, a significant number of patients still have apoor prognosis, probably owing to the increase in the generation of reactive oxygen species (ROS)during the reperfusion of damaged tissue. Oxidative stress and inflammation can be avoided bymodulating mitochondrial function and have been identified as potential targets for the treatmentof cerebral ischemia. In recent years, the beneficial actions of flavonoids and polyphenols againstcerebrovascular diseases have been extensively investigated. The use of resveratrol (RSV) has beenshown to markedly decrease brain damage caused by ischemia in numerous studies. According toin vitro and in vivo experiments, there is growing evidence that RSV is involved in several pathways,including cAMP/AMPK/SIRT1 regulation, JAK/ERK/STAT signaling pathway modulation, TLR4signal transduction regulation, gut/brain axis modulation, GLUT3 up-regulation inhibition, neuronalautophagy activation, and de novo SUR1 expression inhibition. In this review, we summarize therecent outcomes based on the neuroprotective effect of RSV itself and RSV-loaded nanoparticlesin vitro and in vivo models focusing on such mechanisms of action as well as describing the potentialtherapeutic strategies in which RSV plays an active role in cases of ischemic brain injuryFil: Machado, Noelia Daiana. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; Argentina. Universidad Nacional de Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada; ArgentinaFil: Villena Armas, Gorka. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; EspañaFil: Fernández, Mariana Adela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigaciones en Físico-química de Córdoba. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Instituto de Investigaciones en Físico-química de Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; ArgentinaFil: Grijalvo, Santiago. Institute For Advanced Chemistry Of Catalonia; España. Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine; EspañaFil: Díaz Díaz, David. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; España. Universitat Regensburg; AlemaniaMultidisciplinary Digital Publishing Institute2021-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/172967Machado, Noelia Daiana; Villena Armas, Gorka; Fernández, Mariana Adela; Grijalvo, Santiago; Díaz Díaz, David; Neuroprotective Effects of Resveratrol in Ischemic Brain Injury; Multidisciplinary Digital Publishing Institute; NeuroSci; 2; 3; 9-2021; 305-3192673-4087CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/ 10.3390/neurosci2030022info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/2673-4087/2/3/22info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:45:25Zoai:ri.conicet.gov.ar:11336/172967instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:45:25.952CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
title Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
spellingShingle Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
Machado, Noelia Daiana
BLOOD BRAIN BARRIER
BRAIN
ISCHEMIA
NEUROPROTECTION
OXIDATIVE STRESS
POLYPHENOLS
RESVERATROL
title_short Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
title_full Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
title_fullStr Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
title_full_unstemmed Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
title_sort Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
dc.creator.none.fl_str_mv Machado, Noelia Daiana
Villena Armas, Gorka
Fernández, Mariana Adela
Grijalvo, Santiago
Díaz Díaz, David
author Machado, Noelia Daiana
author_facet Machado, Noelia Daiana
Villena Armas, Gorka
Fernández, Mariana Adela
Grijalvo, Santiago
Díaz Díaz, David
author_role author
author2 Villena Armas, Gorka
Fernández, Mariana Adela
Grijalvo, Santiago
Díaz Díaz, David
author2_role author
author
author
author
dc.subject.none.fl_str_mv BLOOD BRAIN BARRIER
BRAIN
ISCHEMIA
NEUROPROTECTION
OXIDATIVE STRESS
POLYPHENOLS
RESVERATROL
topic BLOOD BRAIN BARRIER
BRAIN
ISCHEMIA
NEUROPROTECTION
OXIDATIVE STRESS
POLYPHENOLS
RESVERATROL
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.4
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Cerebral ischemia represents the third cause of death and the first cause of disability inadults. This process results from decreasing cerebral blood flow levels as a result of the occlusionof a major cerebral artery. This restriction in blood supply generates low levels of oxygen andglucose, which leads to a decrease in the energy metabolism of the cell, producing inflammation, andfinally, neurological deterioration. Currently, blood restoration of flow is the only effective approachas a therapy in terms of ischemic stroke. However, a significant number of patients still have apoor prognosis, probably owing to the increase in the generation of reactive oxygen species (ROS)during the reperfusion of damaged tissue. Oxidative stress and inflammation can be avoided bymodulating mitochondrial function and have been identified as potential targets for the treatmentof cerebral ischemia. In recent years, the beneficial actions of flavonoids and polyphenols againstcerebrovascular diseases have been extensively investigated. The use of resveratrol (RSV) has beenshown to markedly decrease brain damage caused by ischemia in numerous studies. According toin vitro and in vivo experiments, there is growing evidence that RSV is involved in several pathways,including cAMP/AMPK/SIRT1 regulation, JAK/ERK/STAT signaling pathway modulation, TLR4signal transduction regulation, gut/brain axis modulation, GLUT3 up-regulation inhibition, neuronalautophagy activation, and de novo SUR1 expression inhibition. In this review, we summarize therecent outcomes based on the neuroprotective effect of RSV itself and RSV-loaded nanoparticlesin vitro and in vivo models focusing on such mechanisms of action as well as describing the potentialtherapeutic strategies in which RSV plays an active role in cases of ischemic brain injury
Fil: Machado, Noelia Daiana. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; Argentina. Universidad Nacional de Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada; Argentina
Fil: Villena Armas, Gorka. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; España
Fil: Fernández, Mariana Adela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigaciones en Físico-química de Córdoba. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Instituto de Investigaciones en Físico-química de Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; Argentina
Fil: Grijalvo, Santiago. Institute For Advanced Chemistry Of Catalonia; España. Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine; España
Fil: Díaz Díaz, David. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; España. Universitat Regensburg; Alemania
description Cerebral ischemia represents the third cause of death and the first cause of disability inadults. This process results from decreasing cerebral blood flow levels as a result of the occlusionof a major cerebral artery. This restriction in blood supply generates low levels of oxygen andglucose, which leads to a decrease in the energy metabolism of the cell, producing inflammation, andfinally, neurological deterioration. Currently, blood restoration of flow is the only effective approachas a therapy in terms of ischemic stroke. However, a significant number of patients still have apoor prognosis, probably owing to the increase in the generation of reactive oxygen species (ROS)during the reperfusion of damaged tissue. Oxidative stress and inflammation can be avoided bymodulating mitochondrial function and have been identified as potential targets for the treatmentof cerebral ischemia. In recent years, the beneficial actions of flavonoids and polyphenols againstcerebrovascular diseases have been extensively investigated. The use of resveratrol (RSV) has beenshown to markedly decrease brain damage caused by ischemia in numerous studies. According toin vitro and in vivo experiments, there is growing evidence that RSV is involved in several pathways,including cAMP/AMPK/SIRT1 regulation, JAK/ERK/STAT signaling pathway modulation, TLR4signal transduction regulation, gut/brain axis modulation, GLUT3 up-regulation inhibition, neuronalautophagy activation, and de novo SUR1 expression inhibition. In this review, we summarize therecent outcomes based on the neuroprotective effect of RSV itself and RSV-loaded nanoparticlesin vitro and in vivo models focusing on such mechanisms of action as well as describing the potentialtherapeutic strategies in which RSV plays an active role in cases of ischemic brain injury
publishDate 2021
dc.date.none.fl_str_mv 2021-09
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/172967
Machado, Noelia Daiana; Villena Armas, Gorka; Fernández, Mariana Adela; Grijalvo, Santiago; Díaz Díaz, David; Neuroprotective Effects of Resveratrol in Ischemic Brain Injury; Multidisciplinary Digital Publishing Institute; NeuroSci; 2; 3; 9-2021; 305-319
2673-4087
CONICET Digital
CONICET
url http://hdl.handle.net/11336/172967
identifier_str_mv Machado, Noelia Daiana; Villena Armas, Gorka; Fernández, Mariana Adela; Grijalvo, Santiago; Díaz Díaz, David; Neuroprotective Effects of Resveratrol in Ischemic Brain Injury; Multidisciplinary Digital Publishing Institute; NeuroSci; 2; 3; 9-2021; 305-319
2673-4087
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/ 10.3390/neurosci2030022
info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/2673-4087/2/3/22
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute
publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268730073022464
score 13.13397